Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-14

Clinical Trial Update: A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and effectiveness of ustekinumab (Stelara) in Chinese patients with psoriasis. Results have been posted (ClinicalTrials.gov …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-14